Clinical Trial Update: Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tamoxifen citrate or Z-Endoxifen hydrochloride in locally advanced or metastatic estrogen receptor-positive, HER2-negative breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Tamoxifen citrate (tamoxifen citrate)
• Z-Endoxifen Hydrochloride (Z-Endoxifen hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-09-28